View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Sponsored by Modality Solutions

The Challenges of Cold Chain Validation for Regenerative Medicine

Free White Paper

The Challenges of Cold Chain Validation for Regenerative Medicine

By Modality Solutions

The Challenges of Cold Chain Validation for Regenerative Medicine

By Modality Solutions
Enter your details to receive the free paper:

Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell injections; immunotherapy, regeneration by biologically active molecules administered alone or as secretions by infused cells; and tissue engineering, transplantation of laboratory-grown organs and tissues.

The combination of the severity of the illness and limited availability of autologous blood supply from the patient creates an elevated risk profile. Existing supply chains were never intended to effectively manage risk for a drug that targets only one single patient.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU